-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

More Than a Disease: Exploring the Patient Journey for Chronic Immune Thrombocytopenia

Sponsor: an independent educational grant from Argenx US, Inc., Sanofi, and Novartis Oncology.
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Diseases, Therapies, Adverse Events
Friday, December 8, 2023: 11:00 AM-2:00 PM
Marriott Grand Ballroom 2-4 (Marriott Marquis San Diego Marina)
Spero Cataland, MD, Ohio State University Comprehensive Cancer Center
Cataland: Takeda: Consultancy; Sanofi: Consultancy.
Srikanth Nagalla, MBBS, ARRAY(0x1001ebf4) and Marie Scully, MD, University College London
Nagalla: Alexion, Sanofi, Agios, Apellis, Rigel, Sobi: Speakers Bureau; Alexion Pharmaceuticals, Sanofi, Agios, Apellis, Rigel, Sobi, Pharmacosmos: Consultancy. Scully: Alexion: Research Funding; Takeda: Honoraria, Research Funding, Speakers Bureau; Sanofi: Honoraria, Speakers Bureau; Octopharma: Speakers Bureau.
On Demand program will be available here January 8, 2024.

This 90-minute, live, interactive symposium will feature expert faculty as well as a patient with ITP to underscore the value of the patient voice throughout the management of ITP. Expert faculty will provide a detailed overview of the mechanisms of ITP and its key clinical features, present diagnostic and treatment challenges and how to overcome them, as well as discuss data on current and emerging therapies to inform the best clinical choices for patients. A big emphasis will be placed on the importance of shared-decision making with the interdisciplinary team for improving outcomes for their patients. Interactive polling questions and a Q&A session will allow for audience engagement and added learning.